Kazakhstan vs Upper-middle income (World Bank): Hypertension treatment coverage among adults aged 30-79 with
Kazakhstan
70.5%
in 2019
Upper-middle income (World Bank)
42.9%
in 2019
Kazakhstan rank
4th
Upper-middle income (World Bank) rank
4th
Hypertension treatment coverage among adults aged 30-79 with over time
- Kazakhstan
- Upper-middle income (World Bank)
How they compare
Kazakhstan currently reports 70.5% against 42.9% in Upper-middle income (World Bank), a difference of 27.6%.
That makes Kazakhstan's figure about 1.6 times Upper-middle income (World Bank)'s.
Across all 30 years both countries report, Kazakhstan has been ahead every year.
Kazakhstan ranks 4th and Upper-middle income (World Bank) ranks 4th of 193 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Upper-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 43.9% | 22.8% | 21.2% | Kazakhstan |
| 2000s | 56.8% | 33.8% | 23.0% | Kazakhstan |
| 2010s | 67.2% | 41.7% | 25.5% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, Kazakhstan or Upper-middle income (World Bank)?
- Kazakhstan, at 70.5% against 42.9% in Upper-middle income (World Bank) as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between Kazakhstan and Upper-middle income (World Bank)?
- 27.6%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Upper-middle income (World Bank)?
- 30 years are reported by both, from 1990 to 2019.
- How do Kazakhstan and Upper-middle income (World Bank) rank globally for hypertension treatment coverage among adults aged 30-79 with?
- Kazakhstan ranks 4th and Upper-middle income (World Bank) ranks 4th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.